ArticleFrontiers in immunology2021

Daratumumab Prevents Experimental Xenogeneic Graft-Versus-Host Disease by Skewing Proportions of T Cell Functional Subsets and Inhibiting T Cell Activation and Migration.

Yang Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.